Biophysics in Biotech and Pharma
Sunday, February 21, 2027
10:45 AM - 12:45 PM
Biophysics is increasingly at the center of modern biotechnology and pharmaceutical discovery, providing the quantitative and mechanistic insights needed to translate fundamental science into new therapeutics. This symposium will bring together leaders from industry to showcase how biophysical approaches are driving innovation across drug discovery, biologics development, structural biology, and therapeutic design.
The session will highlight the diverse ways biophysicists contribute to solving challenging problems in the biotechnology and pharmaceutical sectors. Speakers will discuss the application of cutting-edge biophysical methods to understand molecular mechanisms, characterize drug targets, optimize therapeutic candidates, and accelerate decision-making throughout the development pipeline.
Attendees will gain insight into the evolving role of biophysics in industry, emerging technologies that are reshaping therapeutic discovery, and the interdisciplinary collaborations required to move scientific advances from the laboratory to the clinic. In addition to scientific perspectives, the symposium will provide a valuable opportunity to learn about career paths and leadership experiences in biotech and pharma.
Whether you are a student exploring industry careers, an academic researcher interested in translational science, or a scientist working in drug discovery, this symposium will offer a compelling look at how biophysical principles and technologies are enabling the next generation of medicines
Speakers
Erin Dueber, Genentech, USA
Sandra Gabelli, Merck and Co., USA
Ann Marie Stanley, AstraZeneca, USA
Robert Trachman, New England Biolabs, USA
Chair
Karen Fleming, Johns Hopkins University USA